Breast Cancer 2021: Much Progress, But Work Remains – WebMD

Harold J. Burstein, MD, PhD, breast oncologist, Dana-Farber Cancer Institute; professor of medicine, Harvard Medical School, Boston.

Matthew J. Piotrowski, MD, assistant professor of breast surgical oncology and fellowship program associate director, Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston.

Marina Sharifi, MD, PhD, fellow, hematology, medical oncology, and palliative care, University of Wisconsin Carbone Cancer Center, Madison.

Kari B. Wisinski, MD, interim division chief, hematology, medical oncology, and palliative care; co-lead, Breast Disease-Oriented Team, University of Wisconsin Carbone Cancer Center, Madison.

Yuan Yuan, MD, PhD, breast oncologist and associate professor of medical oncology and therapeutics research, City of Hope Cancer Center, Duarte, CA.

American Cancer Society: "How Common Is Breast Cancer?" "Survival Rates for Breast Cancer," "Targeted Drug Therapy for Breast Cancer,"

"Breast Cancer Facts & Figures 2019-2020."

National Cancer Institute: "Advances in Breast Cancer Research," "Breast Cancer Screening."

Mayo Clinic: "Diagnosing breast cancer" "HER2-positive breast cancer: What is it?" "Paget's Disease of the Breast."

MD Anderson Cancer Center: "6 advances in breast cancer diagnosis and treatment."

Breastcancer.org: "Tumor Genomic Assays."

Clinical Advances in Hematology and Oncology: "Advances in the Treatment of Early-Stage HER2-Positive Breast Cancer."

National Comprehensive Cancer Network: "Genetic/Familial High-Risk Assessment: Breast and Ovarian. 2019.''

Journal of the National Cancer Institute: "Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic."

OpenNotes.org: "Federal Rules Mandating Open Notes."

Here is the original post:

Breast Cancer 2021: Much Progress, But Work Remains - WebMD